From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s

World J Gastrointest Surg. 2022 Jul 27;14(7):632-655. doi: 10.4240/wjgs.v14.i7.632.

Abstract

Colonoscopy represents the most widespread and effective tool for the prevention and treatment of early stage preneoplastic and neoplastic lesions in the panorama of cancer screening. In the world there are different approaches to the topic of colorectal cancer prevention and screening: different starting ages (45-50 years); different initial screening tools such as fecal occult blood with immunohistochemical or immune-enzymatic tests; recto-sigmoidoscopy; and colonoscopy. The key aspects of this scenario are composed of a proper bowel preparation that ensures a valid diagnostic examination, experienced endoscopist in detection of preneoplastic and early neoplastic lesions and open-minded to upcoming artificial intelligence-aided examination, knowledge in the field of resection of these lesions (from cold-snaring, through endoscopic mucosal resection and endoscopic submucosal dissection, up to advanced tools), and management of complications.

Keywords: Adverse events; Cold-endoscopic mucosal resection; Colorectal lesions; Colorectal tumor; Complications; Endoscopic mucosal resection; Endoscopic submucosal dissection; FTRD®; Polypectomy.

Publication types

  • Review